Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Bioverativ Inc (BIVV)

52.20 +1.28 (+2.51%)

3/28/2017  11:34am

Open:

50.95

Pre. Close:

50.92

High:

52.33

Low:

50.95

Volume:

534,400

Market Cap:

5.64B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-03-28 11:19:46 AM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 63.31     One year: 73.94

Support:

Support1: 50.02    Support2: 47.43

Resistance:

Resistance1: 54.20    Resistance2: 63.31

Pivot:

51.16

Moving Averages:

MA(5): 50.95     MA(20): 51.48

MA(100):     MA(250):

MACD:

MACD(12,26): 0.64     Signal(12,26,9): 0.89

%K %D:

%K(14,3): 48.72     %D(3): 44.37

RSI:

RSI(14): 58.30

52-Week:

High: 54.20  Low: 40.00  Change(%): 15.1

Average Vol(K):

3-Month: -10000000000  10-Days 1818

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BIVV has closed below upper band by 39.0%. Bollinger Bands are 0% narrower than normal.

Headline News

Mon, 27 Mar 2017 21:00:00 GMT
Bioverativ Target Raised On 10-K Data

Mon, 27 Mar 2017 11:48:45 GMT
Bioverativ Inc (BIVV) PT Raised to $57 at Stifel Following FY16 Report and ...

Thu, 02 Mar 2017 13:33:13 GMT
Bioverativ Inc. (BIVV) Appoints Anna Protopapas to Board of Directors

Tue, 28 Feb 2017 11:15:00 GMT
Piper Jaffray Upgrades Bioverativ Inc (BIVV) to Overweight

Fri, 24 Mar 2017 12:33:45 GMT
Analyst's Predictions on Pinnacle Foods Inc. (PF), Bioverativ Inc. (BIVV)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  NA

Industry:  NA

Shares Out. (M)

108.00

Shares Float (M)

% Held by Insiders

% Held by Institutions

Shares Short (K)

4080

Shares Short Prior Month (K)

2250

Stock Financials

EPS

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

PEG Ratio

0.65

Profit Margin

35.16

Operating Margin

37.20

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

42.7

Gross Profit (p.s.)

Sales Per Share

7.457

EBITDA (p.s.)

3.176

Qtrly Earnings Growth

59.10

Operating Cash Flow (M)

280.40

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

P/E Growth Ratio

P/BV

P/S

6.94

P/CF

19.93

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.